Advertisement
U.S. markets close in 1 hour 13 minutes
Advertisement
Series Premiere:

Lead This Way, 3 p.m. ET: Abercrombie & Fitch CEO reveals her turnaround playbook

Dechra Pharmaceuticals PLC (DPHAY)

Other OTC - Other OTC Delayed Price. Currency in USD
94.280.00 (0.00%)
As of 10:43AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close94.28
Open94.77
BidN/A x N/A
AskN/A x N/A
Day's Range94.28 - 94.28
52 Week Range60.65 - 98.00
Volume91
Avg. Volume0
Market Cap5.369B
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-0.59
Earnings DateN/A
Forward Dividend & Yield1.09 (1.16%)
Ex-Dividend DateMar 09, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for DPHAY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • DECHRA PHARMACEUTICALS UNSP ADR
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, valuations attractive for media firms; Europe's equity market outlook; raising our expectations on Broadcom; and Chr. Hansen, TBP Group, and BorgWarner.
    Rating
    Fair Value
    Economic Moat
    5 months agoMorningstar
View more